According to Heska Corporation 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -62.171. At the end of 2022 the company had a P/E ratio of -32.2.
Year | P/E ratio | Change |
---|---|---|
2022 | -32.2 | -98.24% |
2021 | < -1000 | 2055.05% |
2020 | -84.7 | -83.23% |
2019 | -505 | -569.17% |
2018 | 108 | 89.19% |
2017 | 56.9 | 23.15% |
2016 | 46.2 | -4.46% |
2015 | 48.4 | 17.34% |
2014 | 41.2 | -199.23% |
2013 | -41.5 | -212.78% |
2012 | 36.8 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Novartis NVS | 26.3 | -142.30% | ๐จ๐ญ Switzerland |
Pfizer PFE | 14.1 | -122.72% | ๐บ๐ธ USA |
Eli Lilly LLY | 135 | -316.92% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | 49.9 | -180.22% | ๐บ๐ธ USA |
Zoetis ZTS | 30.7 | -149.33% | ๐บ๐ธ USA |
Merck MRK | 69.7 | -212.14% | ๐บ๐ธ USA |
Petco WOOF | 12.0 | -119.30% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.